Related Experiment Video
Updated: Feb 19, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
[Management of high thrombus burden in primary PCI]
Insights
Managing large thrombus burdens during percutaneous coronary intervention requires specific strategies. Thromboaspiration and dedicated stents offer options, but careful technique and consideration of delayed stenting are crucial for optimal outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Large thrombus burden is a frequent finding in primary percutaneous coronary intervention.
- This condition is associated with an increased risk of procedural complications.
Purpose of the Study:
- To discuss the management of large thrombus burdens during primary percutaneous coronary intervention.
- To evaluate the roles of intracoronary thrombolysis, glycoprotein IIb/IIIa inhibitors, and thromboaspiration.
- To review dedicated thrombus management stents and stenting strategies.
Main Methods:
- Discussion of current therapeutic options and their limitations.
- Review of techniques for thromboaspiration and use of dedicated stents.
- Consideration of direct versus delayed stenting approaches.
Main Results:
- Thromboaspiration requires specific techniques, and filter capacities can be exceeded.
- Stents designed for thrombus management have specific benefits and drawbacks.
- Direct stenting is generally encouraged, but delayed stenting may be considered for severe thrombotic cases.
Conclusions:
- Optimal management of large thrombus burden involves a combination of pharmacotherapy and mechanical approaches.
- Careful technique is essential for effective thromboaspiration.
- Delayed stenting warrants consideration in select cases with significant thrombotic burden.
Abstract:
A large thrombus burden is not uncommon in primary percutaneous coronary intervention, and is associated with more frequent complications. The role of intracoronary thrombolysis and glycoprotein IIb/IIIa inhibitors in the management of a large thrombus burden is discussed. The use of thromboaspiration must follow a particular logic and used with rigorous manipulations; the capacities of the protective filters are often exceeded. Stents dedicated to thrombus management can be used. Interest and limits of these stents are developed. Direct stenting should be encouraged, and delayed stenting probably considered for the most important thrombotic burden despite "negative" results in studies.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

